Hôpital Jeanne de Flandres
Lille, France
NCT Number: NCT03565770
The purpose of this project is to assess the introduction of an individual follow-up distance coaching (phone and messages on a secure line platform) in order to optimize the health care of type 1 diabetes children with therapy adjustment difficulties. It is a personalized, multi-disciplinary, medical et paramedical. It will consist of an individual coaching for the children and families with therapy adjustment difficulties.
The hypothesis is that the proposed coaching would allow to improve the patient glycemic control not only during this coaching, but also, to bring long lasting improvement following the coaching.
Looking for future studies?
Notify MeUp to 18 year
All sexes
Interventional
Not applicable
Lille, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
coaching on the phone or with messages on line twice a month in order to help patients to adjust their insulin doses and fill in their self-assessment test.
completion of the self-assessment test at inclusion, at M6 and M12 for all study participants
Time frame: at 6 months
Time frame: at baseline, at 3 months, at 12 months
Time frame: at 6 months
Time frame: at baseline, at 6 months, at 12 months
Time frame: at baseline, at 6 months, at 12 months
Time frame: at 6 months
University Hospital, Lille
Other
Assessment of Individual Follow-up by Reference Nurses (Telemedicine Coaching Program) for Type 1 Diabetes Children With Therapy Adjustment Difficulties
Acronym: DIAB-HELP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06190756
Diabetes Mellitus, Diabetes type1
Caen, France
View Trial DetailsNCT05669547
Autoimmune Diseases, Diabetes
Amersfoort, Netherlands
View Trial DetailsNCT05933460
Autoimmune Diseases, Diabetes Mellitus
Thessaloniki, Central Macedonia, Greece
View Trial DetailsNCT05574062
Children, Only, Diabetes type1
Espoo, Finland
View Trial Details